Using proton magnetic resonance spectroscopy, Choi et al. [23] showed that 2-hydroxyglutarate (2HG) correlates with the presence of IDH1 and IDH2 mutations in gliomas. This evidence concerns the gene IDH2 and central nervous system cancer.